Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has been shown to limit hormone responsiveness, but the mechanisms involved in this process are poorly understood. The glucocorticoid receptor is a phosphoprotein that upon ligand binding becomes hyperphosphorylated, and recent evidence indicates that phosphorylation status of the glucocorticoid receptor plays a prominent role in receptor protein turnover. Because phosphorylation is a key signal for ubiquitination and proteasomal catabolism of many proteins, we evaluated whether the ubiquitin-proteasomal pathway had a role in glucocorticoid receptor down-regulation and the subsequent transcriptional response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse glucocorticoid receptor with the proteasome inhibitor MG-132 effectively blocks glucocorticoid receptor protein down-regulation by the glucocorticoid dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor beta-lactone significantly enhanced hormone response of transfected mouse glucocorticoid receptor toward transcriptional activation of glucocorticoid receptor-mediated reporter gene expression. The transcriptional activity of the endogenous human glucocorticoid receptor in HeLa cells was also enhanced by MG-132. Direct evidence for ubiquitination of the glucocorticoid receptor was obtained by immunoprecipitation of cellular extracts from proteasome-impaired cells. Examination of the primary sequence of mouse, human, and rat glucocorticoid receptor has identified a candidate PEST degradation motif. Mutation of Lys-426 within this PEST element both abrogated ligand-dependent down-regulation of glucocorticoid receptor protein and simultaneously enhanced glucocorticoid receptor-induced transcriptional activation of gene expression. Unlike wild type GR, proteasomal inhibition failed to enhance significantly transcriptional activity of K426A mutant GR. Together these findings suggest a major role of the ubiquitin-proteasome pathway in regulating glucocorticoid receptor protein turnover, thereby providing a mechanism to terminate glucocorticoid responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR is ubiquitinated at a conserved lysine residue located at position 419 (Lys-419), and this modification targets the receptor for degradation by the 26S proteasome (Fig.3B)78,79.”
From Corticosteroids (2016) · cites this paper as [79]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Research works printed but not linked: 11
- Sapolsky, 2000, Endocr. Rev., 21, 55
- McKay, 1999, Endocr. Rev., 20, 435
- Bellingham, 1992, Mol. Endocrinol., 6, 2090
- Oakley, 1993, Crit. Rev. Eukaryotic Gene Expr., 3, 63
- Schmidt, 1994, Receptor, 4, 229
- Burnstein, 1994, Mol. Endocrinol., 8, 1764
- Danielsen, 1989, Cancer Res., 49, 2286
- McKay, 2000, Mol. Endocrinol., 14, 1222
- Whitesell, 1996, Mol. Endocrinol., 10, 705
- Vedeckis, 1989, Cancer Res., 49, 2295
- Nawaz, 1999, Cancer Res., 59, 372
Cited by
Items 101–200 of 404
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
Dejager, L., Vandevyver, S., Πέττα, Ι., & Libert, C. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.12.006 · Cited by 85
“Altered phosphorylation of GR can also change its nuclear/ cytoplasmic shuttling by targeting GR for ubiquitin-mediated proteasomal degradation, which affects the receptor half-life [11].”
BackgroundWang, X., & DeFranco, D. B. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0383 · Cited by 77
Sionov, R. V., Spokoini, R., Kfir‐Erenfeld, S., Cohen, O., & Yefenof, E. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00406-5 · Cited by 88
“Lys426 of mouse GR within the PEST sequence is important for ligand‐dependent downregulation of GR (Wallace and Cidlowski, 2001).”
BackgroundInfluentialCao, Y., Bender, I. K., Konstantinidis, A. K., Shin, S. C., Jewell, C. M., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Blood · doi:10.1182/blood-2012-05-432336 · Cited by 76
“All GR translational isoforms have similar turnover rates(28) because all GR isoforms have the same PEST domain that serves as the interaction domain between GR and proteasomes.(39) It has been reported that mRNA-specific structures regulate alternative translation of heat shock protein 70 and several viral genes.”
Self-citationFiorini, M., Ballarò, C., Sala, G., Falcone, G., Alemà, S., & Segatto, O. (2002) · Oncogene · doi:10.1038/sj.onc.1205823 · Cited by 85
“…is affected by proteasome inhibitors The RALT protein contains two blocks of PEST sequences (Fiorentino et al., 2000), a feature typical of labile proteins that may be degraded by the 26S proteasome (Huggins et al., 1999; Oberg et al., 2001; Salama et al., 1994; Wallace and Cidlowski, 2001).”
BackgroundLi, H., Su, P., Lai, T. K. Y., Jiang, A., Liu, J., Zhai, D., Campbell, C., Lee, F. H. F., Yong, W., Pasricha, S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130363 · Cited by 81
“In general, phosphorylation of GR protects it from degradation (32, 33).”
BackgroundGlucocorticoid-Refractory Acute Graft-versus-Host Disease
Pidala, J., & Anasetti, C. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.01.007 · Cited by 75
Lesovaya, E. A., Yemelyanov, A. Y., Swart, A. C., Swart, P., Haegeman, G., & Budunova, I. V. (2015) · Oncotarget · doi:10.18632/oncotarget.5078 · Cited by 78
“com/oncotarget prevent Gcs-induced GR degradation [86, 87].”
Walther, R. F., Atlas, E., Carrigan, A., Rouleau, Y., Edgecombe, A., Visentin, L., Lamprecht, C., Addicks, G. C., Haché, R. J. G., & Lefebvre, Y. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501548200 · Cited by 68
Induced protein degradation for therapeutics: past, present, and future
Yoon, H., Rutter, J. C., Li, Y.-D., & Ebert, B. L. (2024) · Journal of Clinical Investigation · doi:10.1172/jci175265 · Cited by 67
“In response to ligands, NHRs alter transcriptional programs and, in many cases, are subsequently degraded via the ubiquitin-proteasome system (104), including thyroid hormone receptor (105), progesterone receptor (106), ER (107), glucocorticoid receptor (GR) (108), and PPAR γ (109).”
Lives and Times of Nuclear Receptors
Alarid, E. T. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0481 · Cited by 78
Specific Ubiquitin-Conjugating Enzymes Promote Degradation of Specific Nuclear Receptor Coactivators
Yan, F., Gao, X., Lonard, D. M., & Nawaz, Z. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0209 · Cited by 70
Dennis, A. P., & O’Malley, B. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.015 · Cited by 83
Mechanisms of glucocorticoid action and insensitivity in airways disease
Boardman, C., Chachi, L., Gavrila, A., Keenan, C. R., Perry, M. M., Xia, Y., Meurs, H., & Sharma, P. K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.008 · Cited by 82
“Lastly, the GR can also be ubiquitinated and targeted for proteasomal degradation, implying that proteasome inhibitors might reverse glucocorticoid resistance [104].”
BackgroundHoang, T., Fenne, I. S., Cook, C., Børud, B., Bakke, M., Lien, E. A., & Mellgren, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409746200 · Cited by 68
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability
Tsai, J. M., Aguirre, J. D., Li, Y.-D., Brown, J., Focht, V., Kater, L., Kempf, G., Sandoval, B., Schmitt, S., Rutter, J. C., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.028 · Cited by 68
The glucocorticoid receptor signalling in breast cancer
Moutsatsou, P., & Papavassiliou, A. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00177.x · Cited by 65
“The ubiquitin-proteasome-mediated degradation pathway regulates also the glucocorticoid signalling system by controlling the degradation rates of GR [42].”
BackgroundIt takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 74
Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice
Van Bogaert, T., Vandevyver, S., Dejager, L., Van Hauwermeiren, F., Pinheiro, I., Petta, I., Engblom, D., Kleyman, A., Schütz, G., Tuckermann, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212365 · Cited by 64
Dose- and time-dependent glucocorticoid receptor signaling in podocytes
Guess, A. J., Agrawal, S., Wei, C., Ransom, R. F., Benndorf, R., & Smoyer, W. E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00161.2010 · Cited by 66
Paul-Clark, M. J., Roviezzo, F., Flower, R. J., Cirino, G., Del Soldato, P., Adcock, I. M., & Perretti, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3245 · Cited by 66
“Moreover, recent data from Cidlowski and colleague (36) showed FIGURE 4.”
BackgroundGlucocorticoid Receptor Signaling in Diabetes
Kokkinopoulou, I., Diakoumi, A., & Moutsatsou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011173 · Cited by 70
Tirard, M., Almeida, O. F. X., Hutzler, P., Melchior, F., & Michaelidis, T. M. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.01.010 · Cited by 68
“…proteasome system can exert disparate effects on the transcriptional properties of individual steroid receptors, e.g. interference with ERα- or PR-mediated transcription, but enhancement of GR transactivation(Deroo et al., 2002, Lange et al., 2000, Lonard et al., 2000, Wallace and Cidlowski, 2001).”
BackgroundHidalgo, A. A., Deeb, K. K., Pike, J. W., Johnson, C. S., & Trump, D. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244061 · Cited by 63
Dennis, A. P., Lonard, D. M., Nawaz, Z., & O’Malley, B. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.11.009 · Cited by 71
Filipović, D., Gavrilović, L., Dronjak, S., & Radojčić, M. B. (2005) · Neuropsychobiology · doi:10.1159/000084168 · Cited by 61
Noguchi, T., Makino, S., Matsumoto, R., Nakayama, S., Nishiyama, M., Terada, Y., & Hashimoto, K. (2010) · Endocrinology · doi:10.1210/en.2010-0266 · Cited by 60
Tateishi, Y., Sonoo, R., Sekiya, Y.-I., Sunahara, N., Kawano, M., Wayama, M., Hirota, R., Kawabe, Y.-I., Murayama, A., Kato, S., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00713-06 · Cited by 68
“Several nuclear receptors, such as the ER and those for progesterone, glucocorticoid, thyroid hormone receptor, retinoid X, and retinoic acid, are ubiquitinated and degraded in the course of their nuclear activities (8, 11, 13, 26, 29, 32, 36, 47, 51 , 57).”
BackgroundWitchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Lysine 419 targets human glucocorticoid receptor for proteasomal degradation
Wallace, A. D., Cao, Y., Chandramouleeswaran, S., & Cidlowski, J. A. (2010) · Steroids · doi:10.1016/j.steroids.2010.06.015 · Cited by 54
“Our previous work has demonstrated that the mouse glucocorticoid receptor protein undergoes down-regulation in response to hormone binding via the proteasome protein degradation pathway [22].”
BackgroundMethodSelf-citationGlucocorticoid Receptor: A Multifaceted Actor in Breast Cancer
Noureddine, L. M., Trédan, O., Hussein, N., Badran, B. M., Romancer, M. L., & Poulard, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094446 · Cited by 59
“GR is ubiquitinated at K419, targeting GR for degradation by the proteasome [81,82].”
BackgroundKfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 61
“phosphorylation affects ubiquitinylation of GR on Lys426 that marks GR for proteasomal degradation [183].”
BackgroundNuclear hormone receptor degradation and gene transcription: An update
Ismail, A., & Nawaz, Z. (2005) · IUBMB Life · doi:10.1080/15216540500147163 · Cited by 61
“On the contrary, proteasome inhibition enhances both VDR and GR-mediated transactivation ( 45, 52 ).”
BackgroundRegulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway
Zassadowski, F., Rochette‐Egly, C., Chomienne, C., & Cassinat, B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.08.003 · Cited by 60
RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity
Druker, J., Liberman, A. C., Antunica-Noguerol, M., Gerez, J., Páez-Pereda, M., Rein, T., Iñiguez-Lluhí, J. A., Holsboer, F., & ARZT, E. S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01470-12 · Cited by 63
Glucocorticoid Pathways in Chronic Obstructive Pulmonary Disease Therapy
Adcock, I. M., & Ito, K. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-035sr · Cited by 62
“In addition, evidence suggests that GR phosphorylation is involved in receptor turnover and that phosphorylation can target the receptor for hormone-mediated degradation ( 82 ).”
BackgroundBoone, A. N., & Vijayan, M. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00125.2002 · Cited by 65
“As elevated levels of glucocorticoid, either due to stressor exposure and/or pathological conditions, cause GR downregulation and restrict GR signalling (13), it appears likely that GR dynamics may be involved in the attenuated hsp70 response with cortisol (9), but this has not been tested before.”
BackgroundInfluentialDisease- and treatment-associated acquired glucocorticoid resistance
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Endocrine Connections · doi:10.1530/ec-18-0421 · Cited by 58
Yemelyanov, A. Y., Bhalla, P., Yang, X. J., Ugolkov, A. V., Iwadate, K., Karseladze, A. I., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18945 · Cited by 57
Pace, E., Gagliardo, R. P., Melis, M. R., Grutta, S. L., Ferraro, M., Siena, L., Bonsignore, G., Gjomarkaj, M., Bousquet, J. J., & Vignola, A. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.052 · Cited by 53
“Moreover, it is also conceivable that the reduced response to FP in PMA-pretreated PBTs might be linked to PKC activation, which in turn leads to increased GR turnover and GR downregulation.(24,25) Another route related to the modulation of apoptosis by glucocorticoids is through NF-kB, a transcription factor induced…”
BackgroundChen, Q., Jia, A., Snyder, S. A., Gong, Z., & Lam, S. H. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.09.089 · Cited by 55
Thal, S. C., Schaible, E., Neuhaus, W., Scheffer, D., Brandstetter, M., Engelhard, K., Wunder, C., & Förster, C. Y. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827ca494 · Cited by 53
Proteasome‐mediated proteostasis: Novel medicinal and pharmacological strategies for diseases
Mishra, R., Upadhyay, A., Prajapati, V. K., & Mishra, A. (2018) · Medicinal Research Reviews · doi:10.1002/med.21502 · Cited by 52
du Souich, P., & Fradette, C. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.586630 · Cited by 54
“There is evidence that the expression of AhR [105], CAR [106], PXR [107], VDR [108], HNF4 [102], GR [109] and Arnt [110] proteins is regulated by the UPS.”
BackgroundStabilization of the Unliganded Glucocorticoid Receptor by TSG101
Ismaili, N., Blind, R., & Garabedian, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500059200 · Cited by 50
Avenant, C., Ronacher, K., Stubsrud, E., Louw, A., & Hapgood, J. P. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.007 · Cited by 49
Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor
Cohen, D. M., & Steger, D. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.04.001 · Cited by 46
“Consistent with observations showing ligand-stimulated degradation of GR [89], the model proposes that both monomers and dimers are available in limiting amounts so that gain of occupancy at one set of sites leads to loss at another.”
BackgroundExpression and Regulation of Glucocorticoid Receptor in Human Placental Villous Fibroblasts
Lee, M.-J., Wang, Z., Yee, H., Ma, Y., Swenson, N., Yang, L., Kadner, S. S., Baergen, R. N., Logan, S. K., Garabedian, M. J., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0235 · Cited by 49
Alarid, E. T., Preisler-Mashek, M. T., & Solodin, N. M. (2003) · Endocrinology · doi:10.1210/en.2002-0092 · Cited by 48
Malyukova, A., Brown, S., Papa, R. A., O’Brien, R., Giles, J. E., Trahair, T. N., Pozza, L. D., Sutton, R., Liu, T., Haber, M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.361 · Cited by 50
Bitto, A., Polito, F., Burnett, B. P., Levy, R. M., Stefano, V. D., Armbruster, M. A., Marini, H. R., Minutoli, L., Altavilla, D., & Squadrito, F. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0552 · Cited by 50
“Moreover, Wallace & Cidlowski (2001) found that a proteosome–ubiquitin pathway regulates the production of GC receptors.”
BackgroundMode of Glucocorticoid Actions in Airway Disease
Ito, K., Getting, S., & Charron, C. E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.274 · Cited by 54
“In addition, recent evidence suggests that GR phosphorylation is involved in receptor turnover and that phosphorylation can target the receptor for hormone-mediated degradation[76].”
BackgroundInfluentialProteasome Inhibitors Reduce Luciferase and β-Galactosidase Activity in Tissue Culture Cells
Deroo, B. J., & Archer, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200173200 · Cited by 49
Glucocorticoid receptor mutants: man-made tools for functional research
Beck, I. M. E., Bosscher, K. D., & Haegeman, G. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.03.009 · Cited by 58
Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
Clarisse, D., Offner, F. C., & Bosscher, K. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188430 · Cited by 53
“1)[19,131], GC-induced GR ubiquitination, which targets GR for proteasomal degradation[186], is equally likely involved in GC resistance.”
BackgroundEstradiol Binding to Maxi-K Channels Induces Their Down-regulation via Proteasomal Degradation
Korovkina, V. P., Brainard, A. M., Ismail, P., Schmidt, T. J., & England, S. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309158200 · Cited by 52
Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells
Koubovec, D., Berghe, W. V., Vermeulen, L., Haegeman, G., & Hapgood, J. P. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.03.006 · Cited by 47
Kinyamu, H. K., & Archer, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02162-06 · Cited by 55
“In the case of the GR, inhibiting proteolysis of the receptor by the proteasome-specific inhibitor MG132 results in an increase in GR-mediated transcriptional activation from the mouse mammary tumor virus (MMTV) promoter (8, 52 ).”
BackgroundPræstholm, S. M., Correia, C. M., & Grøntved, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572981 · Cited by 49
Hodyl, N. A., Wyper, H., Osei-Kumah, A., Scott, N. M., Murphy, V. E., Gibson, P. G., Smith, R., & Clifton, V. L. (2010) · Thorax · doi:10.1136/thx.2009.123091 · Cited by 46
“Glucocorticoid-dependent suppression of GR expression (ie, homologous downregulation) has been shown to be a mechanism involved in limiting hormone responsiveness.”
BackgroundDu, J., Li, M., Zhang, D., Zhu, X., Zhang, W., Gu, W., Feng, Y., Zhai, X., & Ling, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2763 · Cited by 44
“In several tissues and cultured cells lines, administration of a GR agonist results in a significant down-regulation of GR. This result has been demonstrated in vitro by whole cell ligandbinding assays and western-blot in HeLa and COS-1 cells as well as cultured lymphocytes [ 30-32 ].”
BackgroundCirculating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy
Shen, L., Huang, F., Ye, L., Zhu, W., Zhang, X., Wang, S., Wang, W., & Ning, G. (2015) · Endocrine · doi:10.1007/s12020-014-0487-4 · Cited by 46
Brégégère, F. M., Milner, Y., & Friguet, B. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.09.002 · Cited by 49
The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression
Lynch, J. T., Rajendran, R., Xenaki, G., Berrou, I., Demonacos, C., & Krstic–Demonacos, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-38 · Cited by 49
“Phosphorylation of the receptor modulates its transcriptional activity, alters its protein stability and subcellular location [11-14].”
BackgroundGlucocorticoid Receptor Phosphorylation Modulates Transcription Efficacy through GRIP-1 Recruitment
Avenant, C., Kotitschke, A., & Hapgood, J. P. (2010) · Biochemistry · doi:10.1021/bi901956s · Cited by 41
Ubiquitylation of nuclear receptors: new linkages and therapeutic implications
Helzer, K. T., Hooper, C., Miyamoto, S., & Alarid, E. T. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0308 · Cited by 45
“The TR, GR and mineralocorticoid receptor (MR) were also found to be down-regulated in response to ligand binding via a similar pathway (Dace et al. 2000, Wallace & Cidlowski 2001, Yokota et al. 2004).”
Vazzana, M., Vizzini, A., Sanfratello, M. A., Celi, M., Salerno, G., & Parrinello, N. (2010) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2010.05.003 · Cited by 43
“According to Wallace and Cidlowski (2001), the possibility exists that the injected medium (vehicle) does not activate the DlGR1 gene transcription whereas the GR protein could be diminished as an effect of a proteasoma-mediated degradation due to the physiologically enhanced plasma cortisol…”
BackgroundHe, B., Zhang, N., & Zhao, R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25076 · Cited by 46
“It has been demonstrated that synthetic GCs disrupt cell cycle regulation and suppress cell proliferation in b-cells (Colvin et al., 2013), gonadotropes (Wehmeyer et al., 2014) and neurons (Samarasinghe et al., 2012).”
BackgroundWang, X., Pongrac, J. L., & DeFranco, D. B. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0287 · Cited by 43
“This seems at odds with previous results where GR transactivation was enhanced accompanying proteasome inhibition (30, 33).”
BackgroundResultInfluentialGR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
Louw, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01693 · Cited by 46
“Further elucidation of the process has established that inhibition of transcription is mediated through binding of the liganded-GR to a nGRE in exon 6 of the GR gene and assembly of a repressive complex, consisting of the GR, the coregulator NCoR1, and histone deacetylase 3 (HDAC3), at the transcriptional start site t…”
BackgroundLiver X Receptor Ligands Suppress Ubiquitination and Degradation of LXRα by Displacing BARD1/BRCA1
Kim, K. H., Yoon, J. M., Choi, A. H., Kim, W. S., Lee, G. Y., & Kim, J. B. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0295 · Cited by 37
Glucocorticoid resistance — what is known?
Norman, M., & Hearing, S. D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00232-1 · Cited by 41
Rimando, M. G., Wu, H.-H., Liu, Y.-A., Lee, C., Kuo, S.-W., Lo, Y.-P., Tseng, K., Liu, Y., & Lee, O. K. (2016) · Scientific Reports · doi:10.1038/srep37371 · Cited by 43
Gan, Y., Wang, C., He, R.-H., Hsu, P.-C., Yeh, H.-H., Hsieh, T.-H., Lin, H., Cheng, M.-Y., Jeng, C., Huang, M., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02517-8 · Cited by 43
“S4A) possibly due to activation-induced proteasome degradation [51, 52]; this finding differs from that on the increase in the GR level observed in the LPS model that was not affected by Fkbp5 deficiency.”
ResultHarke, N. N., Leers, J., Kietz, S., Drenckhahn, D., & Förster, C. Y. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.011 · Cited by 48
Ahi1 regulates the nuclear translocation of glucocorticoid receptor to modulate stress response
Wang, B., Xin, N., Qian, X., Zhai, L., Miao, Z., Yong, Y., Li, S., Sun, M., Xu, X., & Li, X. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01305-x · Cited by 42
The Co-repressor Hairless Protects RORα Orphan Nuclear Receptor from Proteasome-mediated Degradation
Moraitis, A. N., & Giguère, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308152200 · Cited by 39
The Management of Glucocorticoid Therapy in Liver Failure
Xue, R., & Meng, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02490 · Cited by 45
“Moreover, post-translational modifications of GR also contribute to a reduced GC response, such as ubiquitination of the GR (Lys-426 within a PEST element) and phosphorylation of the GR (68, 70).”
BackgroundYokota, K., Shibata, H., Kobayashi, S., Suda, N., Murai‐Takeda, A., Kurihara, I., Saito, I., & Saruta, T. (2004) · Endocrine Research · doi:10.1081/erc-200043783 · Cited by 42
Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia
Chen, D. W.-C., Saha, V., Liu, J.-Z., Schwartz, J., & Krstic–Demonacos, M. (2012) · Oncogene · doi:10.1038/onc.2012.321 · Cited by 45
Zhang, X., Clark, A. F., & Yorio, T. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0697 · Cited by 45
Role of the ubiquitin–proteasome pathway in the diagnosis of human diseases
Gołąb, J., Bauer, T. M., Daniel, V., & Naujokat, C. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.025 · Cited by 43
Kumar, R. (2008) · Biologics: Targets & Therapy · doi:10.2147/btt.s3820 · Cited by 34
“Co-transfection Co-transfection data from Cidlowski and colleagues (Webster et al 1997; Wallace et al 2001) have shown that phosphorylated mouse GR had a half-life of 8–9 h in the presence of agonist, whereas mutations of multiple GR phosphorylation sites increased its half-life to 32 h.”
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies
Sionov, R. V. (2013) · ISRN Hematology · doi:10.1155/2013/348212 · Cited by 37
“Phosphorylation of GR modulates its transcriptional activity, alters its protein stability and subcellular location [192–195].”
BackgroundTesticular Receptor-4: Novel Regulator of Glucocorticoid Resistance
Zhang, D., Du, L., & Heaney, A. P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1379 · Cited by 35
“This rapid and specific negative regulation of ACTH mediated by GC action in the anterior pituitary is largely attributable to the binding of the liganded GR to the 5 -flanking region of the POMC gene (14).”
BackgroundSpies, L.-M. L., Verhoog, N. J. D., & Louw, A. (2021) · Cells · doi:10.3390/cells10102529 · Cited by 37
“Previous studies have identified the single site for ubiquitination to be within the PEST (a peptide sequence that is rich in proline (P), glutamic acid (E), serine (S), and threonine (T) residues) degradation motif at lysine 426 (K426) in mice and lysine 419 (K419) in humans [61,66].”
BackgroundKino, T., Liou, S.-H., Charmandari, E., & Chrousos, G. P. (2004) · Molecular Medicine · doi:10.2119/2005-00026.kino · Cited by 34
Lesovaya, E. A., Yemelyanov, A. Y., Игоревич, К. К., Попа, А. В., Belitsky, G. A., Геннадиевна, Я. М., Gordon, L. I., Rosen, S. T., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.23048 · Cited by 35
“It is known that proteasome inhibitors can stabilize GR both in steroid-treated and -untreated cells.(26,35) Thus, we expected that BZ will accumulate GR protein and, consequently, enhance CpdA ligand properties, further shifting GR activity toward transrepression.”
BackgroundAspectos moleculares da sensibilidade aos glicocorticóides
Faria, C. D. C., & Longui, C. A. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000600003 · Cited by 39
The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp
Liu, T., Sun, Y., & Bai, W. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00976-8 · Cited by 34
Kfir‐Erenfeld, S., Haggiag, N., Biton, M., Stepensky, P., Asherie, N., & Yefenof, E. (2016) · Oncotarget · doi:10.18632/oncotarget.13447 · Cited by 33
“When GC-resistant cells are treated by the hormone, GR is not upregulated and even downregulated as a consequence of proteasomal degradation [65, 66].”
BackgroundFeed-Forward Inhibition of Androgen Receptor Activity by Glucocorticoid Action in Human Adipocytes
Hartig, S. M., He, B., Newberg, J. Y., Ochsner, S. A., Loose, D. S., Lanz, R. B., McKenna, N. J., Buehrer, B. M., McGuire, S. E., Marcelli, M., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.07.020 · Cited by 34
“Addition of dex to differentiation components (ixr) caused a decrease in GR protein levels (ixr+dex: −21% vs EtOH) consistent with a ligand- and proteasome-dependent downregulation mechanism (Wallace and Cidlowski, 2001).”
BackgroundRegulation of Peroxisome Proliferator–Activated Receptor-α by MDM2
Gopinathan, L., Hannon, D. B., Peters, J. M., & Heuvel, J. P. V. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn260 · Cited by 33
“Degradation of NRs such as retinoic acid receptor (RARc2), progesterone receptor (PR) and GR is linked to transcriptional activation (Gianni et al., 2002; Shen et al., 2001; Wallace and Cidlowski, 2001).”
Ahn, S.-Y., Park, J., An, I., Jung, S. J., & Hwang, J. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2384 · Cited by 30
“To determine whether TRPV1 is degraded by cortisol-induced autophagy, we treated HeLa cells, which constitutively express functional cortisol receptors (Wallace and Cidlowski, 2001), with various concentrations of cortisol for 24 h (Fig.”
Zhao, X., Peng, T., Cao, X., Hou, Y., Li, R., Han, T., Fan, Z., Zhao, M., Chang, Y., Chen, H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111342 · Cited by 36
Keenan, C. R., Mok, S.-L., Harris, T., Xia, Y., Salem, S., & Stewart, A. G. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-55 · Cited by 31
“Determination of GRα protein expression showed a significant reduction by 30 nM dexamethasone treatment, according with expectations based on previous studies in A549, BEAS-2B and HeLa epithelial cell lines [20,21].”
Jiang, L., Dasgupta, I., Hurcombe, J., Colyer, H. F., Mathieson, P. W., & Welsh, G. I. (2015) · Clinical Science · doi:10.1042/cs20140749 · Cited by 30
Role of 14-3-3η as a Positive Regulator of the Glucocorticoid Receptor Transcriptional Activation
Kim, Y. S., Jang, S.-W., Sung, H. J., Lee, H. J., Kim, I. S., Na, D. S., & Ko, J. (2005) · Endocrinology · doi:10.1210/en.2004-1455 · Cited by 32
Ren, Y., Xu, X., Mao, C.-Y., Han, K., Xu, Y., Cao, B., Zhang, Z.-B., Sethi, G., Tang, X., & Mao, X. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0309-6 · Cited by 30
Chapter 13 Xenobiotic impact on corticosteroid signaling
Vijayan, M. M., Prunet, P., & Boone, A. N. (2005) · Biochemistry and molecular biology of fishes · doi:10.1016/s1873-0140(05)80016-5 · Cited by 58
Metadata
- Authors
- Wallace, A. D., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- ORCID
- Cidlowski, John A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 46
- Pages
- 42714-42721
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984573021
- Cited by
- 394
- References
- 65
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 12 · 2017: 14 · 2016: 10 · 2015: 16 · 2014: 15 · 2013: 25 · 2012: 19
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6924 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- glucocorticoid receptor, receptor down-regulation, ubiquitin-proteasome system, proteasome inhibition, MG132, dexamethasone, receptor phosphorylation, ubiquitination, transcriptional activation, hormone responsiveness
- MeSH terms
- Animals, Cysteine Endopeptidases, Dexamethasone, Glucocorticoids, HeLa Cells, Humans, Ligands, Luciferases, Lysine, Multienzyme Complexes, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Receptors, Glucocorticoid, Time Factors, Transcription, Genetic, Transfection, Blotting, Western, Signal Transduction, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, COS Cells, Amino Acid Motifs, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.